Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Substance P Receptor Antagonist I: Conversion of Phosphoramidate Prodrug after i.v. Administration to Rats and Dogs

Su-Er W. Huskey, Debra Luffer-Atlas, Brian J. Dean, Erin M. McGowan, William P. Feeney and Shuet-Hing Lee Chiu
Drug Metabolism and Disposition November 1999, 27 (11) 1367-1373;
Su-Er W. Huskey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra Luffer-Atlas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Dean
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin M. McGowan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William P. Feeney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuet-Hing Lee Chiu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 27 no. 11 1367-1373
PubMed 
10534323

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 26, 1999
  • Accepted August 10, 1999
  • Published online November 1, 1999.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Su-Er W. Huskey1,
  2. Debra Luffer-Atlas1,
  3. Brian J. Dean1,
  4. Erin M. McGowan1,
  5. William P. Feeney2 and
  6. Shuet-Hing Lee Chiu1
  1. 1Department of Drug Metabolism (S.-E.W.H., D.L.-A., B.J.D., E.M.M., S.-H.L.C.) and 2Laboratory Animal Resources (W.P.F.), Merck Research Laboratories. Rahway, New Jersey
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to March 2023

    AbstractFullPdf
    Aug 2017074
    Sep 20170916
    Oct 20170155
    Nov 20170157
    Dec 2017061
    Jan 20181186
    Feb 2018044
    Mar 2018193
    Apr 20182187
    May 20181137
    Jun 20180144
    Jul 20181148
    Aug 2018162
    Sep 2018030
    Oct 2018052
    Nov 2018064
    Dec 2018901
    Jan 20191521
    Feb 2019516
    Mar 2019500
    Apr 20191000
    May 20191601
    Jun 2019615
    Jul 20191132
    Aug 20192430
    Oct 20191400
    Nov 20191700
    Dec 20191521
    Jan 20201210
    Feb 20201612
    Mar 2020800
    May 20202721
    Jun 20202812
    Jul 20201011
    Aug 20201212
    Sep 20202533
    Oct 20202141
    Nov 20201541
    Dec 20202711
    Jan 20211410
    Feb 2021921
    Mar 2021510
    Apr 2021910
    May 20212810
    Jun 20211321
    Jul 20211110
    Aug 2021710
    Sep 2021410
    Oct 2021620
    Nov 20212922
    Dec 20211310
    Jan 2022410
    Feb 2022422
    Mar 2022310
    Apr 2022310
    May 2022410
    Jun 2022910
    Jul 20223331
    Aug 2022611
    Sep 20221321
    Oct 2022910
    Nov 20221310
    Dec 2022310
    Jan 20231710
    Feb 20231110
    Mar 2023010

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition: 27 (11)
    Drug Metabolism and Disposition
    Vol. 27, Issue 11
    1 Nov 1999
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Substance P Receptor Antagonist I: Conversion of Phosphoramidate Prodrug after i.v. Administration to Rats and Dogs
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Substance P Receptor Antagonist I: Conversion of Phosphoramidate Prodrug after i.v. Administration to Rats and Dogs

    Su-Er W. Huskey, Debra Luffer-Atlas, Brian J. Dean, Erin M. McGowan, William P. Feeney and Shuet-Hing Lee Chiu
    Drug Metabolism and Disposition November 1, 1999, 27 (11) 1367-1373;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Substance P Receptor Antagonist I: Conversion of Phosphoramidate Prodrug after i.v. Administration to Rats and Dogs

    Su-Er W. Huskey, Debra Luffer-Atlas, Brian J. Dean, Erin M. McGowan, William P. Feeney and Shuet-Hing Lee Chiu
    Drug Metabolism and Disposition November 1, 1999, 27 (11) 1367-1373;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • AKRs and GUSs in Testosterone Disposition
    • Olanzapine Glucuronidation in Humanized Mice
    • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics